Showing results (41-50 of 215) with videos related to

Sort By:
Pageof 22
The British Journal of Ophthalmology|July 25, 2020
Photophobia: shared pathophysiology underlying dry eye disease, migraine and traumatic brain injury leading to central neuroplasticity of the trigeminothalamic pathwayRyan J Diel, Divy Mehra, Randy Kardon, et al.
Headache|March 14, 2012
Factors associated with triptan use in episodic migraine: results from the American Migraine Prevalence and Prevention StudyMin Kyung Chu, Dawn C Buse, Marcelo E Bigal, et al.
Headache|April 18, 2015
Acute treatment optimization in episodic and chronic migraine: results of the American Migraine Prevalence and Prevention (AMPP) StudyDaniel Serrano, Dawn C Buse, Aubrey Manack Adams, et al.
Headache|February 16, 2023
Longitudinal assessment of comorbidities and co-occurring conditions in adolescents with migraine: A secondary analysis of the National Longitudinal Study of Adolescent to Adult Health (Add Health)James S McGinley, Andrea Savord, Dawn C Buse, et al.
Pain Medicine (Malden, Mass.)|February 11, 2022
Combining Guided Intervention of Education and Relaxation (GIER) with Remote Electrical Neuromodulation (REN) in the Acute Treatment of MigraineDawn C Buse, Liron Rabany, Tamar Lin, et al.
Headache|October 24, 2014
Methodological issues in studying trigger factors and premonitory features of migraineRichard B Lipton, Jelena M Pavlovic, Sheryl R Haut, et al.
The Journal of Headache and Pain|July 28, 2022
Optimization of acute medication use following eptinezumab initiation during a migraine attack: post hoc analysis of the RELIEF studyRoger Cady, Richard B Lipton, Dawn C Buse, et al.
Headache|October 22, 2020
Demographics, Headache Features, and Comorbidity Profiles in Relation to Headache Frequency in People With Migraine: Results of the American Migraine Prevalence and Prevention (AMPP) StudyDawn C Buse, Michael L Reed, Kristina M Fanning, et al.
Headache|June 29, 2016
A Comparison of the Chronic Migraine Epidemiology and Outcomes (CaMEO) Study and American Migraine Prevalence and Prevention (AMPP) Study: Demographics and Headache-Related DisabilityRichard B Lipton, Aubrey Manack Adams, Dawn C Buse, et al.
Headache|September 8, 2017
Faster Improvement in Migraine Pain Intensity and Migraine-Related Disability at Early Time Points with AVP-825 (Sumatriptan Nasal Powder Delivery System) versus Oral Sumatriptan: A Comparative Randomized Clinical Trial Across Multiple Attacks from the COMPASS StudyRichard B Lipton, James S McGinley, Kenneth J Shulman, et al.
Pageof 22